Max S Wicha

This inventor holds 19 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Cancer Treatment. Top assignees: University of Michigan, University of Iowa Research Foundation, Other. Active years: 2006-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Max S Wicha. Retrieved from https://idiyas.com/inventor/max-s-wicha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 3)

% Patents Active = 63.2

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 279(Granted Patents)

Company Filing History:

18 out of 3,550

University of Michigan

patents

1 out of 925

University of Iowa Research Foundation

patents

1 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2022

Loading Chart...

Areas of Expertise:

Whole Cell Analysis

Microfluidic Device

Rare Cell Detection

Solid Tumor Stem Cells

Cancer Treatment

CXCR1 Compositions

Notch4 Signaling

Breast Cancer

ALDH1 Marker

Tumor Targeting

Stem Cell Methods

Cancer Therapies

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11426729 - Systems and methods for whole cell analysis (2022-08-30),

2. 10677708 - Microfluidic device and method for detecting rare cells (2020-06-09),

3. 10557850 - Anti-CXCR1 compositions and methods (2020-02-11),

4. 10227567 - Isolation and use of solid tumor stem cells (2019-03-12),

5. 10073024 - Microfluidic device and method for detecting rare cells (2018-09-11),

6. 9801922 - Compositions and methods of treating cancer (2017-10-31),

7. 9606124 - Methods of detecting and treating stem-cell containing solid tumors (2017-03-28),

8. 9492538 - Isolation and use of solid tumor stem cells (2016-11-15),

9. 9352039 - Method of reducing the number of EMT and MET type breast cancer stem cells (2016-05-31),

10. 9327023 - HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells (2016-05-03),

11. 9089556 - Method for treating cancer using an antibody that inhibits notch4 signaling (2015-07-28),

12. 8940301 - Breast tumor treatment with anti-CXCR1 compositions (2015-01-27),

13. 8435746 - Aldehyde dehydrogenase 1 (ALDH1) as a cancer stem cell marker (2013-05-07),

14. 8357491 - Isolation and use of solid tumor stem cells (2013-01-22),

15. 7850961 - Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist (2010-12-14),

Title: Max S. Wicha: A Pioneer in Cell Analysis Innovations

Introduction

Max S. Wicha, based in Ann Arbor, MI, is a renowned inventor with a remarkable portfolio of 19 patents that significantly contribute to the fields of cell analysis and biomedical engineering. His pioneering work has led to several groundbreaking inventions that enhance the understanding and manipulation of cellular systems.

Latest Patents

Among his latest innovations, two patents stand out for their technological advancements. The first one, titled "Systems and methods for whole cell analysis," focuses on single-cell genomic analysis, particularly in gene expression studies. This innovation offers new possibilities for researchers working in genomics and cellular biology.

The second patent, "Microfluidic device and method for detecting rare cells," presents a sophisticated microfluidic device designed to isolate rare cells from a fluid sample. The device includes a unique labyrinth channel structure that effectively separates rare cells from other cells, allowing for more precise analysis. This patent emphasizes the importance of the inertial lift forces and Dean flow in enhancing the separation process within the device.

Career Highlights

Max S. Wicha’s professional journey includes positions at prestigious institutions such as the University of Michigan and the University of Iowa Research Foundation. His contributions in these roles not only enriched his expertise but also propelled his inventions forward, making them valuable assets in the scientific community.

Collaborations

Throughout his career, Wicha has collaborated with notable professionals, including Michael F. Clarke and Muhammad Al-Hajj. These partnerships have fostered an environment of innovation and teamwork, further amplifying the impact of their combined efforts in the field of biomedical research.

Conclusion

Max S. Wicha's innovations in cell analysis are a testament to his dedication and ingenuity as an inventor. With a strong portfolio of patents, he continues to inspire the scientific community by leading advancements in genomic analysis and cell detection technology. His work remains crucial for researchers striving to uncover the complexities of cellular functions and disease mechanisms.

Profile summary based on public USPTO records.